Type 2 diabetes mellitus and gout
Gout is the most common inflammatory arthritis in adults and has continued to increase in prevalence over the past decades. Gout is characterized by hyperuricemia with the obligatory crystallization of urates and an associated inflammatory reaction, as well as metabolic effects caused, among other t...
Saved in:
| Main Authors: | O. V. Zhelyabina, M. S. Eliseev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2021-10-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3081 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01) -
Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01) -
Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01) -
Urate-lowering therapy and the risk of developing type 2 diabetes mellitus in patients with gout (results of a prospective study)
by: M. S. Eliseev, et al.
Published: (2023-10-01) -
Rational use of recommendations for urate-lowering therapy: clinical examples
by: M. S. Eliseev, et al.
Published: (2022-06-01)